At a recent meeting on viral vector purification held in Williamsburg ... J.A. Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum.

Download this compendium from The Scientist’s Creative Services Team and Polyplus, now part of Sartorius, to learn more about viral vectors for gene therapy and discover how to enhance recombinant AAV ...

Code and documentation supporting "Targeting AAV vectors to the CNS via de novo engineered capsid-receptor interactions", including data, SVAE-based variant generation method, and figure-generation ...

The capsid license follows an agreement between Dyno and Roche originally announced in May 2020 and marks Dyno’s first adeno-associated virus (AAV) capsid licensing and partnership completion.

Genethon & Eukarÿs enter strategic partnership to develop a breakthrough technology to reduce the biomanufacturing cost of gene therapies: Evry, France Friday, January 24, 2025, ...

The Swiss drugmaker noted it has an exclusive, worldwide license from REGENXBIO (RGNX) for any recombinant AAV vector in its intellectual property portfolio for the in vivo gene therapy treatment ...

New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid Titer, Supporting Reliable Assessment of AAV Vector Quality HERCULES, Calif. ...